Cudkowicz ME - Search Results

1

Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles.

Young C, Pinto S, Grosskreutz J, Hardiman O, Clawson LL, Cudkowicz ME, Andrews JA. Young C, et al. Among authors: cudkowicz me. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):66-75. doi: 10.1080/21678421.2021.1920981. Epub 2021 Aug 14. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 34392765

2

An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Cudkowicz ME, Brown RH Jr. Cudkowicz ME, et al. J Neurol Sci. 1996 Aug;139 Suppl:10-5. doi: 10.1016/0022-510x(96)00084-6. J Neurol Sci. 1996. PMID: 8899652 Review. No abstract available.

3

The ALS Patient Care Database: insights into end-of-life care in ALS.

Mandler RN, Anderson FA Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M; ALS C.A.R.E. Study Group. Mandler RN, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8. doi: 10.1080/14660820152882214. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001. PMID: 11958732

4

Measures and markers in amyotrophic lateral sclerosis.

Cudkowicz M, Qureshi M, Shefner J. Cudkowicz M, et al. NeuroRx. 2004 Apr;1(2):273-83. doi: 10.1602/neurorx.1.2.273. NeuroRx. 2004. PMID: 15717028 Free PMC article. Review.

5

Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising future.

Choudry RB, Cudkowicz ME. Choudry RB, et al. Among authors: cudkowicz me. J Clin Pharmacol. 2005 Dec;45(12):1334-44. doi: 10.1177/0091270005282631. J Clin Pharmacol. 2005. PMID: 16291708 Review.

6

Trial of celecoxib in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB. Cudkowicz ME, et al. Ann Neurol. 2006 Jul;60(1):22-31. doi: 10.1002/ana.20903. Ann Neurol. 2006. PMID: 16802291 Clinical Trial.

7

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).

Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, Hilgenberg S, Smart R, Brown RH, Cudkowicz ME. Qureshi MM, et al. Among authors: cudkowicz me. Amyotroph Lateral Scler. 2006 Sep;7(3):173-82. doi: 10.1080/14660820600640596. Amyotroph Lateral Scler. 2006. PMID: 16963407

8

Therapy development for ALS: lessons learned and path forward.

Lanka V, Cudkowicz M. Lanka V, et al. Amyotroph Lateral Scler. 2008 Jun;9(3):131-40. doi: 10.1080/17482960802112819. Amyotroph Lateral Scler. 2008. PMID: 18574756 Review.

9

Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.

Qureshi M, Shui A, Dibernardo AB, Brown RH Jr, Schoenfeld DA, Cudkowicz ME. Qureshi M, et al. Among authors: cudkowicz me. Amyotroph Lateral Scler. 2008 Dec;9(6):369-74. doi: 10.1080/17482960802163614. Amyotroph Lateral Scler. 2008. PMID: 18608098 Review.

10

Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.

Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, Smith K, Cudkowicz ME, Ferrante RJ. Del Signore SJ, et al. Among authors: cudkowicz me. Amyotroph Lateral Scler. 2009 Apr;10(2):85-94. doi: 10.1080/17482960802226148. Amyotroph Lateral Scler. 2009. PMID: 18618304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters